(Q68737201)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

C M Camaggi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

E Strocchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

R Comparsi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

F Testoni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

B Angelelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

F Pannuti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

47-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00253063

27 September 2019

exact match

0 references

cites work

Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone

1 reference

12 December 2020

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study

1 reference

12 December 2020

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

12 December 2020

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

12 December 2020

Bilary disposition of adriamycin

1 reference

12 December 2020

Separation, characterization, and analysis of epirubicin (4'-epidoxorubicin) and its metabolites from human urine

1 reference

12 December 2020

Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.

1 reference

12 December 2020

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00253063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3463434%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference